Journal of Medical Oncology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +441518081136

Mini Review - Journal of Medical Oncology and Therapeutics (2023) Volume 8, Issue 2

Medical oncology: An overview

Alexander Kennedy*

Department of Medical Oncology, American Society of Clinical Oncology, Alexandria, USA

*Corresponding Author:
Alexander Kennedy
Department of Medical Oncology
American Society of Clinical Oncology
Alexandria, USA
E-mail: kenalex@asco.org

Received: 01-Mar-2023, Manuscript No. JMOT-23-91105; Editor assigned: 02-Mar-2023, PreQC No. JMOT-23-91105(PQ); Reviewed: 16-Mar-2023, QC No. JMOT-23-91105; Revised: 20-Mar-2023, Manuscript No. JMOT-23-91105(R); Published: 25-Mar-2023, DOI: 10.35841/jmot-8.2.138

Citation: Kennedy A. Medical oncology: An overview. J Med Oncl Ther. 2023;8(2):138

Visit for more related articles at Journal of Medical Oncology and Therapeutics

Cancer is a complex and multifaceted disease that can affect any part of the body. Medical oncology is a field of medicine that deals with the diagnosis, treatment, and management of cancer patients. Medical oncologists are specialized physicians who use a wide range of therapies to treat cancer, including chemotherapy, immunotherapy, targeted therapy, and radiation therapy [1]

Medical oncology is a sub-specialty of internal medicine that focuses on the diagnosis and treatment of cancer patients. Medical oncologists are physicians who specialize in the use of chemotherapy, targeted therapy, immunotherapy, and other therapies to treat cancer. Medical oncologists are trained to provide care for all stages of cancer, from diagnosis to treatment and management. Medical oncologists are also involved in the prevention and early detection of cancer. They work closely with other specialists, such as surgical oncologists, radiation oncologists, and pathologists, to provide comprehensive care for cancer patients. Medical oncologists are responsible for the overall management of cancer patients. They work closely with other members of the healthcare team, including nurses, pharmacists, and social workers, to ensure that patients receive the best possible care. Medical oncologists are trained to diagnose cancer and determine the best course of treatment for each individual patient [2].

Medical oncologists also play a key role in managing the side effects of cancer treatments. Chemotherapy and radiation therapy can cause a range of side effects, such as fatigue, nausea, and hair loss. Medical oncologists work with patients to manage these side effects and help them maintain their quality of life during treatment. Medical oncologists also provide ongoing care for cancer patients after treatment is complete. They monitor patients for any signs of recurrence and provide follow-up care to help prevent the cancer from returning. Medical oncologists use a range of tools and techniques to diagnose and treat cancer. Some of the most common diagnostic tests include imaging tests, such as CT scans and MRI scans, and biopsies, which involve the removal of a sample of tissue for examination under a microscope. Once cancer has been diagnosed, medical oncologists work with patients to develop a treatment plan that is tailored to their individual needs. Treatment plans may include chemotherapy, targeted therapy, immunotherapy, radiation therapy, or a combination of these therapies [3].

Chemotherapy involves the use of drugs to kill cancer cells. Chemotherapy drugs can be given orally or intravenously, and are often given in cycles. Targeted therapy is a type of cancer treatment that uses drugs to target specific proteins or genes that are involved in the growth and spread of cancer cells. Immunotherapy is a type of cancer treatment that harnesses the power of the immune system to fight cancer cells. Radiation therapy uses high-energy radiation to kill cancer cells. Radiation therapy can be given externally or internally, and may be used alone or in combination with other treatments.

Medical oncologists are involved in clinical trials, which are research studies that evaluate new treatments for cancer. Clinical trials are essential for advancing the field of medical oncology and improving outcomes for cancer patients. Clinical trials may involve testing new drugs or combinations of drugs, evaluating the effectiveness of immunotherapy or targeted therapy, or exploring new ways to use radiation therapy. Medical oncologists play a key role in designing and conducting clinical trials, and in interpreting the results of these studies.

Medical oncology is a vital field of medicine that is focused on the diagnosis, treatment, and management of cancer patients. Medical oncologists are specialized physicians who use a wide range of therapies to treat cancer, including chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Medical oncologists play a key role in managing the side effects of cancer treatments, and provide ongoing care [4].

Medical oncologists also work closely with other specialists to provide comprehensive care for cancer patients. They may collaborate with surgical oncologists to remove tumours, radiation oncologists to administer radiation therapy, and pathologists to analyze tissue samples and diagnose cancer. One of the primary goals of medical oncology is to develop individualized treatment plans that are tailored to each patient's unique needs. Medical oncologists take into account factors such as the type and stage of cancer, the patient's overall health and medical history, and any genetic or molecular characteristics of the tumour.

In recent years, there has been a growing focus on precision medicine in medical oncology. Precision medicine involves using advanced technologies, such as genomic sequencing, to identify specific mutations or biomarkers in a patient's tumour. This information can then be used to develop targeted therapies that are designed to attack cancer cells with greater precision and effectiveness. Precision medicine has already led to significant improvements in the treatment of certain types of cancer, such as melanoma and lung cancer. However, there is still much to learn about how best to apply precision medicine in different types of cancer and patient populations. Another area of active research in medical oncology is immunotherapy. Immunotherapy involves using the body's own immune system to fight cancer cells. There are several different types of immunotherapy, including checkpoint inhibitors, CAR T-cell therapy, and cancer vaccines [5].

Checkpoint inhibitors are drugs that block certain proteins on the surface of cancer cells, which can prevent the immune system from attacking them. CAR T-cell therapy involves removing T-cells (a type of immune cell) from a patient's blood, modifying them to recognize and attack cancer cells, and then infusing them back into the patient's body. Cancer vaccines are designed to stimulate the immune system to recognize and attack cancer cells. Immunotherapy has shown great promise in the treatment of certain types of cancer, particularly those that are difficult to treat with conventional therapies. However, immunotherapy can also cause significant side effects, and not all patients are eligible for this type of treatment.

In addition to developing new treatments for cancer, medical oncologists also play a critical role in supporting patients and their families throughout the cancer journey. Cancer can have a significant impact on a patient's emotional, social, and financial well-being, and medical oncologists work closely with other healthcare professionals, such as social workers and psychologists, to provide comprehensive support.

References

  1. Kennedy BJ. Medical oncology: Its origin, evolution, current status, and future. Cancer: Interdisciplinary Int J Am Cancer Soc. 1999;85(1):1-8.
  2. Indexed at, Google Scholar, Cross Ref

  3. McNiff KK, Neuss MN, Jacobson JO, et al. Measuring supportive care in medical oncology practice: lessons learned from the quality oncology practice initiative. J Clin Oncol. 2008;26(23):3832-7.
  4. Indexed at, Google Scholar, Cross Ref

  5. Mirzania M, Ghavamzadeh A, Kermani IA, et al. Medical oncology, history and its future in Iran. Arch Iran Med. 2015;18(11):799.
  6. Indexed at, Google Scholar

  7. Leon-Ferre RA, Stover DG. Supporting the future of the oncology workforce: ASCO medical student and trainee initiatives. J Oncol Prac. 2018;14(5):277-80.
  8. Indexed at, Google Scholar, Cross Ref

  9. Isla Casado D, González-Martín A, Alba Conejo E. The relevance of the Spanish Society for Medical Oncology (SEOM)'s clinical oncology guidelines. Clin transl oncol. 2010:707-8.
  10. Indexed at, Google Scholar, Cross Ref

Get the App